APO Research
Talk to an analyst

APO RESEARCH · REPORT

GalNAc-based Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global GalNAc-based Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025192 pages

Choose your research edition.

Industry ResearchGalNAc-based Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal GalNAc-based Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal GalNAc-based Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GalNAc-based Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal GalNAc-based Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global GalNAc-based Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for GalNAc-based Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GalNAc-based Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GalNAc-based Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for GalNAc-based Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GalNAc-based Drug include Suzhou Ribo Life Science Co., Ltd, Sirnaomics, Novartis, Novo Nordisk (Dicerna), Hitgen (Leaderna Therapeutics Ltd.), Silence Therapeutics, Ionis, Arrowhead and Arbutus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global GalNAc-based Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GalNAc-based Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GalNAc-based Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the GalNAc-based Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

GalNAc-based Drug Segment by Company

Suzhou Ribo Life Science Co., Ltd

Sirnaomics

Novartis

Novo Nordisk (Dicerna)

Hitgen (Leaderna Therapeutics Ltd.)

Silence Therapeutics

Ionis

Arrowhead

Arbutus

Alnylam Pharmaceuticals

GalNAc-based Drug Segment by Type

siRNA Based

ASO Based

GalNAc-based Drug Segment by Application

Metabolic Diseases

Neurological Diseases

Cardiovascular Diseases

Other

GalNAc-based Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GalNAc-based Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GalNAc-based Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GalNAc-based Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of GalNAc-based Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GalNAc-based Drug industry.

Chapter 3: Detailed analysis of GalNAc-based Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GalNAc-based Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global GalNAc-based Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of siRNA Based Table 3. Key Players of ASO Based Table 4. Global GalNAc-based Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Metabolic Diseases Table 6. Key Players of Neurological Diseases Table 7. Key Players of Cardiovascular Diseases Table 8. Key Players of Other Table 9. Global GalNAc-based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global GalNAc-based Drug Market Size by Region (2021-2026) & (US$ Million) Table 11. Global GalNAc-based Drug Market Share by Region (2021-2026) Table 12. Global GalNAc-based Drug Market Size by Region (2027-2032) & (US$ Million) Table 13. Global GalNAc-based Drug Market Share by Region (2027-2032) Table 14. GalNAc-based Drug Industry Trends Table 15. GalNAc-based Drug Industry Drivers Table 16. GalNAc-based Drug Industry Opportunities and Challenges Table 17. GalNAc-based Drug Industry Restraints Table 18. Global GalNAc-based Drug Revenue by Company (US$ Million) & (2021-2026) Table 19. Global GalNAc-based Drug Revenue Market Share by Company (2021-2026) Table 20. Global GalNAc-based Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global GalNAc-based Drug Key Company Head Office and Area Served Table 22. Global GalNAc-based Drug Company, Product Type & Application Table 23. Global GalNAc-based Drug Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global GalNAc-based Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global GalNAc-based Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global GalNAc-based Drug Market Size by Type (2021-2026) & (US$ Million) Table 28. Global GalNAc-based Drug Market Size by Type (2027-2032) & (US$ Million) Table 29. Global GalNAc-based Drug Revenue Market Share by Type (2021-2026) Table 30. Global GalNAc-based Drug Revenue Market Share by Type (2027-2032) Table 31. Global GalNAc-based Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global GalNAc-based Drug Market Size by Application (2021-2026) & (US$ Million) Table 33. Global GalNAc-based Drug Market Size by Application (2027-2032) & (US$ Million) Table 34. Global GalNAc-based Drug Revenue Market Share by Application (2021-2026) Table 35. Global GalNAc-based Drug Revenue Market Share by Application (2027-2032) Table 36. Suzhou Ribo Life Science Co., Ltd Company Information Table 37. Suzhou Ribo Life Science Co., Ltd Business Overview Table 38. Suzhou Ribo Life Science Co., Ltd GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Suzhou Ribo Life Science Co., Ltd GalNAc-based Drug Product Portfolio Table 40. Suzhou Ribo Life Science Co., Ltd Recent Development Table 41. Sirnaomics Company Information Table 42. Sirnaomics Business Overview Table 43. Sirnaomics GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sirnaomics GalNAc-based Drug Product Portfolio Table 45. Sirnaomics Recent Development Table 46. Novartis Company Information Table 47. Novartis Business Overview Table 48. Novartis GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Novartis GalNAc-based Drug Product Portfolio Table 50. Novartis Recent Development Table 51. Novo Nordisk (Dicerna) Company Information Table 52. Novo Nordisk (Dicerna) Business Overview Table 53. Novo Nordisk (Dicerna) GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Novo Nordisk (Dicerna) GalNAc-based Drug Product Portfolio Table 55. Novo Nordisk (Dicerna) Recent Development Table 56. Hitgen (Leaderna Therapeutics Ltd.) Company Information Table 57. Hitgen (Leaderna Therapeutics Ltd.) Business Overview Table 58. Hitgen (Leaderna Therapeutics Ltd.) GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Hitgen (Leaderna Therapeutics Ltd.) GalNAc-based Drug Product Portfolio Table 60. Hitgen (Leaderna Therapeutics Ltd.) Recent Development Table 61. Silence Therapeutics Company Information Table 62. Silence Therapeutics Business Overview Table 63. Silence Therapeutics GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Silence Therapeutics GalNAc-based Drug Product Portfolio Table 65. Silence Therapeutics Recent Development Table 66. Ionis Company Information Table 67. Ionis Business Overview Table 68. Ionis GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Ionis GalNAc-based Drug Product Portfolio Table 70. Ionis Recent Development Table 71. Arrowhead Company Information Table 72. Arrowhead Business Overview Table 73. Arrowhead GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Arrowhead GalNAc-based Drug Product Portfolio Table 75. Arrowhead Recent Development Table 76. Arbutus Company Information Table 77. Arbutus Business Overview Table 78. Arbutus GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Arbutus GalNAc-based Drug Product Portfolio Table 80. Arbutus Recent Development Table 81. Alnylam Pharmaceuticals Company Information Table 82. Alnylam Pharmaceuticals Business Overview Table 83. Alnylam Pharmaceuticals GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Alnylam Pharmaceuticals GalNAc-based Drug Product Portfolio Table 85. Alnylam Pharmaceuticals Recent Development Table 86. North America GalNAc-based Drug Market Size by Type (2021-2026) & (US$ Million) Table 87. North America GalNAc-based Drug Market Size by Type (2027-2032) & (US$ Million) Table 88. North America GalNAc-based Drug Market Size by Application (2021-2026) & (US$ Million) Table 89. North America GalNAc-based Drug Market Size by Application (2027-2032) & (US$ Million) Table 90. North America GalNAc-based Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America GalNAc-based Drug Market Size by Country (2021-2026) Table 92. North America GalNAc-based Drug Market Size by Country (2027-2032) Table 93. Europe GalNAc-based Drug Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe GalNAc-based Drug Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe GalNAc-based Drug Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe GalNAc-based Drug Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe GalNAc-based Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe GalNAc-based Drug Market Size by Country (2021-2026) Table 99. Europe GalNAc-based Drug Market Size by Country (2027-2032) Table 100. China GalNAc-based Drug Market Size by Type (2021-2026) & (US$ Million) Table 101. China GalNAc-based Drug Market Size by Type (2027-2032) & (US$ Million) Table 102. China GalNAc-based Drug Market Size by Application (2021-2026) & (US$ Million) Table 103. China GalNAc-based Drug Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia GalNAc-based Drug Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia GalNAc-based Drug Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia GalNAc-based Drug Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia GalNAc-based Drug Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia GalNAc-based Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia GalNAc-based Drug Market Size by Country (2021-2026) Table 110. Asia GalNAc-based Drug Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa GalNAc-based Drug Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa GalNAc-based Drug Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa GalNAc-based Drug Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa GalNAc-based Drug Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa GalNAc-based Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa GalNAc-based Drug Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa GalNAc-based Drug Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. GalNAc-based Drug Product Image Figure 2. Global GalNAc-based Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global GalNAc-based Drug Market Share by Type: 2025 VS 2032 Figure 4. siRNA Based Image Figure 5. ASO Based Image Figure 6. Global GalNAc-based Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global GalNAc-based Drug Market Share by Application: 2025 VS 2032 Figure 8. Metabolic Diseases Image Figure 9. Neurological Diseases Image Figure 10. Cardiovascular Diseases Image Figure 11. Other Image Figure 12. Global GalNAc-based Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 14. Global GalNAc-based Drug Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global GalNAc-based Drug Market Share by Players in 2025 Figure 17. Global Top 5 and 10 GalNAc-based Drug Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global GalNAc-based Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global GalNAc-based Drug Revenue Market Share by Type (2021-2032) Figure 21. Global GalNAc-based Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global GalNAc-based Drug Revenue Market Share by Application (2021-2032) Figure 23. North America GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 24. North America GalNAc-based Drug Market Share by Type (2021-2032) Figure 25. North America GalNAc-based Drug Market Share by Application (2021-2032) Figure 26. North America GalNAc-based Drug Market Share by Country (2021-2032) Figure 27. United States GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 28. Canada GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 29. Mexico GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 30. Europe GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe GalNAc-based Drug Market Share by Type (2021-2032) Figure 32. Europe GalNAc-based Drug Market Share by Application (2021-2032) Figure 33. Europe GalNAc-based Drug Market Share by Country (2021-2032) Figure 34. Germany GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 35. France GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 36. U.K. GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 37. Italy GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 38. Russia GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 40. China GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 41. China GalNAc-based Drug Market Share by Type (2021-2032) Figure 42. China GalNAc-based Drug Market Share by Application (2021-2032) Figure 43. Asia GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 44. Asia GalNAc-based Drug Market Share by Type (2021-2032) Figure 45. Asia GalNAc-based Drug Market Share by Application (2021-2032) Figure 46. Asia GalNAc-based Drug Market Share by Country (2021-2032) Figure 47. Japan GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 48. South Korea GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 51. India GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 52. Australia GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa GalNAc-based Drug Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa GalNAc-based Drug Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa GalNAc-based Drug Market Share by Country (2021-2032) Figure 57. Brazil GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 58. South Africa GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 60. Turkey GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 61. Argentina GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 62. UAE GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 63. Egypt GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 64. Chile GalNAc-based Drug Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • siRNA Based
  • ASO Based
Applications
  • Metabolic Diseases
  • Neurological Diseases
  • Cardiovascular Diseases
  • Other
Companies covered
  • Suzhou Ribo Life Science Co., Ltd
  • Sirnaomics
  • Novartis
  • Novo Nordisk (Dicerna)
  • Hitgen (Leaderna Therapeutics Ltd.)
  • Silence Therapeutics
  • Ionis
  • Arrowhead
  • Arbutus
  • Alnylam Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global GalNAc-based Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 siRNA Based
  5. 1.2.3 ASO Based
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global GalNAc-based Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Metabolic Diseases
  9. 1.3.3 Neurological Diseases
  10. 1.3.4 Cardiovascular Diseases
  11. 1.3.5 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global GalNAc-based Drug Growth Trends by Region
  14. 1.5.1 Global GalNAc-based Drug Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 GalNAc-based Drug Market Size by Region (2021-2026)
  16. 1.5.3 GalNAc-based Drug Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global GalNAc-based Drug Market Dynamics
  1. 2.1 GalNAc-based Drug Industry Trends
  2. 2.2 GalNAc-based Drug Industry Drivers
  3. 2.3 GalNAc-based Drug Industry Opportunities and Challenges
  4. 2.4 GalNAc-based Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global GalNAc-based Drug Revenue by Company (2021-2026)
  2. 3.2 Global GalNAc-based Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global GalNAc-based Drug Key Company Head office and Area Served
  4. 3.4 Global GalNAc-based Drug Company, Product Type & Application
  5. 3.5 Global GalNAc-based Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global GalNAc-based Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 GalNAc-based Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 GalNAc-based Drug Tier 1, Tier 2, and Tier 3
4 GalNAc-based Drug Market by Type
  1. 4.1 Global GalNAc-based Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global GalNAc-based Drug Market Size by Type (2021-2032)
  3. 4.3 Global GalNAc-based Drug Market Size Share by Type (2021-2032)
5 GalNAc-based Drug Market by Application
  1. 5.1 Global GalNAc-based Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global GalNAc-based Drug Market Size by Application (2021-2032)
  3. 5.3 Global GalNAc-based Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Suzhou Ribo Life Science Co., Ltd
  2. 6.1.1 Suzhou Ribo Life Science Co., Ltd Company Information
  3. 6.1.2 Suzhou Ribo Life Science Co., Ltd Business Overview
  4. 6.1.3 Suzhou Ribo Life Science Co., Ltd GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Suzhou Ribo Life Science Co., Ltd GalNAc-based Drug Product Portfolio
  6. 6.1.5 Suzhou Ribo Life Science Co., Ltd Recent Developments
  7. 6.2 Sirnaomics
  8. 6.2.1 Sirnaomics Company Information
  9. 6.2.2 Sirnaomics Business Overview
  10. 6.2.3 Sirnaomics GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sirnaomics GalNAc-based Drug Product Portfolio
  12. 6.2.5 Sirnaomics Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis GalNAc-based Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Novo Nordisk (Dicerna)
  20. 6.4.1 Novo Nordisk (Dicerna) Company Information
  21. 6.4.2 Novo Nordisk (Dicerna) Business Overview
  22. 6.4.3 Novo Nordisk (Dicerna) GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novo Nordisk (Dicerna) GalNAc-based Drug Product Portfolio
  24. 6.4.5 Novo Nordisk (Dicerna) Recent Developments
  25. 6.5 Hitgen (Leaderna Therapeutics Ltd.)
  26. 6.5.1 Hitgen (Leaderna Therapeutics Ltd.) Company Information
  27. 6.5.2 Hitgen (Leaderna Therapeutics Ltd.) Business Overview
  28. 6.5.3 Hitgen (Leaderna Therapeutics Ltd.) GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Hitgen (Leaderna Therapeutics Ltd.) GalNAc-based Drug Product Portfolio
  30. 6.5.5 Hitgen (Leaderna Therapeutics Ltd.) Recent Developments
  31. 6.6 Silence Therapeutics
  32. 6.6.1 Silence Therapeutics Company Information
  33. 6.6.2 Silence Therapeutics Business Overview
  34. 6.6.3 Silence Therapeutics GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Silence Therapeutics GalNAc-based Drug Product Portfolio
  36. 6.6.5 Silence Therapeutics Recent Developments
  37. 6.7 Ionis
  38. 6.7.1 Ionis Company Information
  39. 6.7.2 Ionis Business Overview
  40. 6.7.3 Ionis GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Ionis GalNAc-based Drug Product Portfolio
  42. 6.7.5 Ionis Recent Developments
  43. 6.8 Arrowhead
  44. 6.8.1 Arrowhead Company Information
  45. 6.8.2 Arrowhead Business Overview
  46. 6.8.3 Arrowhead GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Arrowhead GalNAc-based Drug Product Portfolio
  48. 6.8.5 Arrowhead Recent Developments
  49. 6.9 Arbutus
  50. 6.9.1 Arbutus Company Information
  51. 6.9.2 Arbutus Business Overview
  52. 6.9.3 Arbutus GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Arbutus GalNAc-based Drug Product Portfolio
  54. 6.9.5 Arbutus Recent Developments
  55. 6.10 Alnylam Pharmaceuticals
  56. 6.10.1 Alnylam Pharmaceuticals Company Information
  57. 6.10.2 Alnylam Pharmaceuticals Business Overview
  58. 6.10.3 Alnylam Pharmaceuticals GalNAc-based Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Alnylam Pharmaceuticals GalNAc-based Drug Product Portfolio
  60. 6.10.5 Alnylam Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America GalNAc-based Drug Market Size (2021-2032)
  2. 7.2 North America GalNAc-based Drug Market Size by Type
  3. 7.2.1 North America GalNAc-based Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America GalNAc-based Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America GalNAc-based Drug Market Share by Type (2021-2032)
  6. 7.3 North America GalNAc-based Drug Market Size by Application
  7. 7.3.1 North America GalNAc-based Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America GalNAc-based Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America GalNAc-based Drug Market Share by Application (2021-2032)
  10. 7.4 North America GalNAc-based Drug Market Size by Country
  11. 7.4.1 North America GalNAc-based Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America GalNAc-based Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America GalNAc-based Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America GalNAc-based Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe GalNAc-based Drug Market Size (2021-2032)
  2. 8.2 Europe GalNAc-based Drug Market Size by Type
  3. 8.2.1 Europe GalNAc-based Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe GalNAc-based Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe GalNAc-based Drug Market Share by Type (2021-2032)
  6. 8.3 Europe GalNAc-based Drug Market Size by Application
  7. 8.3.1 Europe GalNAc-based Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe GalNAc-based Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe GalNAc-based Drug Market Share by Application (2021-2032)
  10. 8.4 Europe GalNAc-based Drug Market Size by Country
  11. 8.4.1 Europe GalNAc-based Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe GalNAc-based Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe GalNAc-based Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe GalNAc-based Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China GalNAc-based Drug Market Size (2021-2032)
  2. 9.2 China GalNAc-based Drug Market Size by Type
  3. 9.2.1 China GalNAc-based Drug Market Size by Type (2021-2026)
  4. 9.2.2 China GalNAc-based Drug Market Size by Type (2027-2032)
  5. 9.2.3 China GalNAc-based Drug Market Share by Type (2021-2032)
  6. 9.3 China GalNAc-based Drug Market Size by Application
  7. 9.3.1 China GalNAc-based Drug Market Size by Application (2021-2026)
  8. 9.3.2 China GalNAc-based Drug Market Size by Application (2027-2032)
  9. 9.3.3 China GalNAc-based Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia GalNAc-based Drug Market Size (2021-2032)
  2. 10.2 Asia GalNAc-based Drug Market Size by Type
  3. 10.2.1 Asia GalNAc-based Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia GalNAc-based Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia GalNAc-based Drug Market Share by Type (2021-2032)
  6. 10.3 Asia GalNAc-based Drug Market Size by Application
  7. 10.3.1 Asia GalNAc-based Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia GalNAc-based Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia GalNAc-based Drug Market Share by Application (2021-2032)
  10. 10.4 Asia GalNAc-based Drug Market Size by Country
  11. 10.4.1 Asia GalNAc-based Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia GalNAc-based Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia GalNAc-based Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia GalNAc-based Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa GalNAc-based Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa GalNAc-based Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa GalNAc-based Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa GalNAc-based Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa GalNAc-based Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa GalNAc-based Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa GalNAc-based Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa GalNAc-based Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa GalNAc-based Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa GalNAc-based Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa GalNAc-based Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa GalNAc-based Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa GalNAc-based Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa GalNAc-based Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst